Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference42 articles.
1. Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment;Peng;Eur. J. Med. Chem.,2020
2. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents;Mottamal;Molecules,2015
3. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi;Suraweera;Front. Oncol.,2018
4. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3;Meng;Int. J. Oncol.,2013
5. Cancer epigenetics: from mechanism to therapy;Dawson;Cell,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Annual review of PROTAC degraders as anticancer agents in 2022;European Journal of Medicinal Chemistry;2024-03
2. HDAC-targeting epigenetic modulators for cancer immunotherapy;European Journal of Medicinal Chemistry;2024-02
3. Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies;Acta Pharmaceutica Sinica B;2024-02
4. HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation;Cell Chemical Biology;2023-11
5. Exploring Degradation of Intrinsically Disordered Protein YAP induced by PROTACs;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3